Cite
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation.
MLA
Murthy, V., et al. “Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-Term Outcomes With Dose Escalation.” Clinical Oncology, vol. 31, no. 9, Sept. 2019, pp. 646–52. EBSCOhost, https://doi.org/10.1016/j.clon.2019.06.005.
APA
Murthy, V., Gupta, P., Baruah, K., Krishnatry, R., Joshi, A., Prabhash, K., Noronha, V., Menon, S., Pal, M., Prakash, G., & Bakshi, G. (2019). Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation. Clinical Oncology, 31(9), 646–652. https://doi.org/10.1016/j.clon.2019.06.005
Chicago
Murthy, V., P. Gupta, K. Baruah, R. Krishnatry, A. Joshi, K. Prabhash, V. Noronha, et al. 2019. “Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-Term Outcomes With Dose Escalation.” Clinical Oncology 31 (9): 646–52. doi:10.1016/j.clon.2019.06.005.